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A Ab bs st tr ra ac ct t
Denaturing high performance liquid chromatography is a relatively new method by which heteroduplex structures
formed during the PCR amplification of heterozygote samples can be rapidly identified. The use of this technology
for mutation detection in hereditary non-polyposis colorectal cancer (HNPCC) has the potential to appreciably
shorten the time it takes to analyze genes associated with this disorder. Prior to acceptance of this method for
screening genes associated with HNPCC, assessment of the reliability of this method should be performed. In
this report we have compared mutation and polymorphism detection by denaturing gradient gel electrophoresis
(DGGE) with denaturing high performance liquid chromatography (DHPLC) in a set of 130 families. All
mutations/polymorphisms representing base substitutions, deletions, insertions and a 23 base pair inversion
were detected by DHPLC whereas DGGE failed to identify four single base substitutions and a single base pair
deletion. In addition, we show that DHPLC has been used for the identification of 5 different mutations in exon
7 of hMSH2 that could not be detected by DGGE.
From this study we conclude that DHPLC is a more effective and rapid alternative to the detection of mutations
in hMSH2 and hMLH1 with the same or better accuracy than DGGE. Furthermore, this technique offers
opportunities for automation, which have not been realised for the majority of other methods of gene analysis.
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I In nt tr ro od du uc ct ti io on n
HNPCC is an autosomal dominantly inherited
disorder that predisposes mutation carriers to an
increased risk of early onset colorectal cancer in the
absence of any premalignant marker [1]. In addition,
mutation carriers are at risk of developing a range of
other epithelial cancers, which include endometrial
cancer, CNS tumors and cancers of the upper renal
tract [2]. The incidence of HNPCC is not accurately
known, but is estimated to account for between 1%
and 2% of all colorectal cancer patients [3, 4]. 
HNPCC is caused by defects in genes that are
associated with DNA mismatch repair. DNA mismatch
repair is a complex process that involves many genes,
four of which have been directly associated with the
disease. These genes include hMSH2 on chromosome
2p [5, 6], hMLH1 on chromosome 3q [7], hPMS2 on
chromosome 2 [8], and hMHS6 on chromosome 7 [9],
for a detailed review see Papadopoulos and LindblomH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2003; 1(1) 40
[10].  Tumors  arising  in  HNPCC  families  have  a
characteristic  genetic  signature  of  microsatellite
instability (MSI), which can be assayed for by comparing
microsatellite DNA profiles from the tumor to profiles
from constitutional DNA [11, 12].
Two of the four genes account for the majority of
HNPCC families, these being hMSH2 and hMLH1 [13-
16]. Since there are several genes associated with
HNPCC the search for inexpensive, rapid detection
methods are critical if large scale genetic screening
strategies are going to be implemented to offer patients
accurate surveillance measures to improve survival. 
For a mutation-detection strategy to be effective it
must fulfil several requirements. It should have the
capacity to be automated, it ought to be inexpensive
and it must be accurate. To date most mutation
detection strategies do not fulfil all three of these
requirements. Most have not been automated or are
relatively expensive and none have been assessed
properly for their accuracy and this includes direct DNA
sequencing, considered to be the “gold standard”.
There are two mutation detection strategies that are
most commonly used for genes involved in HNPCC,
these being denaturing gradient gel electrophoresis
(DGGE) and single strand conformation polymorphism
analysis (SSCP). A third test, the protein truncation test
(PTT) is also used for mutation detection in HNPCC,
which requires the use of RNA for analysis. Its sensitivity
is limited in that it will only identify nonsense mutations
and premature stop codons [17]. Other techniques do
exist but they are not widely used and suffer from the
problem of being technically difficult (examples of which
include chemical/enzymatic cleavage mismatch assay
and temperature gradient gel electrophoresis) or do
not detect a significant majority of mutations. 
DHPLC is a new technique that lends itself to
automation by virtue of being performed in a column
rather than a gel format and providing a rapid,
inexpensive and reliable assay. This technique is based
on the observation that heteroduplexes will, under
partially denaturing conditions, be more likely to
denature, compared to their homoduplex counterparts
[18]. DHPLC analysis has several advantages compared
to other methods of analysis, which include the absence
of any radioactive labeling or the purchase of purpose
designed oligonucleotides, as is the case with DGGE.
A recent report has compared DHPLC with single
strand conformation polymorphism (SSCP) analysis
and two dimensional gene scanning (TDGE) analysis
and direct sequencing. The results of this comparison
indicate that DHPLC is very similar to direct sequencing
in terms of sensitivity [19]. No comparison has been
reported between DHPLC and DGGE analysis. 
In this report we compare and contrast mutation
detection using DGGE with that of DHPLC using 95
families that have previously been screened by DGGE
analysis revealing 34 changes [20]. A further 30
families were also included in the study as they had
subsequently been shown to harbor changes in hMSH2
or hMLH1. Together the results indicate that DHPLC is
a much more accurate screening assay for the analysis
of genes associated with HNPCC and it can be
performed much more rapidly.
M Ma at te er ri ia al ls s   a an nd d   m me et th ho od ds s
A total of 130 unrelated patients were screened for
mutations and polymorphisms in hMLH1 and hMSH2
using DGGE and DHPLC. The diagnosis of HNPCC
was made on the basis that all patients had family
histories consistent with the Amsterdam criteria [21]. All
patients provided informed consent for genetic studies
after appropriate genetic counseling for HNPCC. 
Genomic  DNA  was  isolated  from  EDTA  blood
according to the method described by Miller et al. [22].
Briefly, blood samples were mixed with erythrocyte lysis
(EL) buffer (155 mM NH4Cl, 10 mM KHCO3, 1 mM
EDTA, pH 7.4). The lysate was centrifuged, washed twice
with  EL  buffer,  and  the  intact  lymphocyte  pellet
resuspended in nuclei lysis (NL) buffer (2ml; 100 mM
TRIS-Cl, pH 8.0, 100 mM NaCl, 2 mM Na2EDTA, 1%
SDS and 1 mg/ml proteinase K), and incubated overnight
at 55
oC. The next day, 333 ul/ml of sample of 6 M NaCl
was added, mixed and centrifuged to remove cellular
proteins from the solution. The supernatant containing
the DNA was placed in a fresh tube and the DNA
precipitated with ethanol. The resulting DNA pellet was
washed  with  70%  ethanol,  dried  briefly  and  then
reconstituted in TE buffer (10 mM TRIS-Cl, pH 8.0, 1
mM EDTA) to a concentration of 500 ng/ul. 
D DG GG GE E  A An na al ly ys si is s
DGGE  analysis  was  essentially  performed
according to the methods of Wijnen et al. [23, 24].
Briefly, PCR amplification was performed using 250 to
500  ng  of  genomic  DNA,  1U  Taq  polymerase
(Boeringher/Mannheim), 200 µM each nucleotide, 4
to 10% glycerol, 10 mM Tris-Cl (pH 9.0), 1.0-5.0 mM
MgCl2 and 1.0 µM concentrations of the appropriate
forward  and  reverse  primers.  A  GC  clamp  was
incorporated at the 5’ end of one primer of each pair
for DGGE analysed as described previously Wijnen et
al [23, 24]. The primer sequences for each exon of
hMSH2 and hMLH1 were exactly as described. PCR
amplification was achieved by an initial denaturation
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at 94
0C for 5 min followed by 35 cycles of 94
0C for 1
min, 55 to 58
0C for 1.5 min and 72
oC for 2 min then
a final extension step at 72
0C for 10 min. DGGE was
performed by separating 5 to 15 µl of PCR product
mixed with an equal volume of gel loading buffer (15%
Ficol1, 0.25% Bromophenol Blue, 0.25% Xylene
Cyanol) on a 10% polyacrylamide gel that contained
a denaturing gradient (100% denaturant is 40%
formamide, 42% w/v urea) suitable for each exon
being analysed (see Table 1 for exon specific gradients).
The gel and electrophoresis buffer were both TAE (40
mM  Tris  acetate  pH  7.5,  1  mM  EDTA).  DGGE
separation was performed overnight for 16 hours at
60
0C and 40 V and visualized by ethidium bromide
staining, UV transillumination and photography.
D DH HP PL LC C  A An na al ly ys si is s
PCR  amplification  for  DHPLC  analysis  was
performed using primers previously designed for SSCP
analysis of both hMLH1 and hMSH2 (see Table 2) with
minor modification. The reaction consisted of 1.0 µM
each primer, 1U Platinum Taq (Gibco-BRL), 2-5 mM
MgCl2 and 200 µM each dNTP .
PCR  amplification  was  achieved  by  an  initial
denaturation at 94
0C for 5 min followed by 14 cycles
of 94
0C for 1 min, 7
0C touchdown range for 1.5 min
and 72
0C for 2 min then 20 cycles using an annealing
temperature 0.5
oC lower than the bottom of the
touchdown range. The annealing step was performed
as a touchdown protocol with a 7
0C range, decreasing
0.5
oC/cycle over 14 cycles. This was followed by a final
extension step at 72
0C for 10 min, a final denaturation
step at 95
0C for 5 min and a slow annealing step from
95
0C to 65
0C over 30 min to promote heteroduplex
formation. The PCR was performed on a PCR express
(Hybaid) instrument equipped with a heated lid to avoid
the use of mineral oil. 
DHPLC analysis was performed using a Varian Helix
system (Varian Inc., Walnut Creek, CA). PCR products
(2-5 µl) were injected directly into a DNA Eclipse (Hewlett
Packard) or Helix (Varian) column and eluted from the
column using an increasing acetonitrile gradient and a
column oven temperature suitable for each exon of
hMLH1 and hMSH2 (see Table 3). Heteroduplexes
formed during PCR of a heterozygote sample were
detected as an additional peak eluting before the
homoduplex peak. The detection of heteroduplexes was
made simpler with the use of DHPLC review software
supplied from Varian. The predicted melting temperatures
of the double stranded DNA products were obtained by
using  the  DHPLC-MELT  program  available  from
http://www.insertion.stanford.edu/melt.html. 
For each segment a negative control fragment
(amplified from DNA isolated from a normal healthy
donor who had no family history of disease) was run
through the denaturing column at the non-denaturing
temperature of 50
0C. The 50
0C peak profile was then
compared to the Stanford melting temperature profile
of  the  respective  fragment  as  well  as  three  1
0C
increments  on  either  side  of  predicted  melting
temperature.  Partially  denatured  conditions  were
established when a shift in retention time of at least or
equal to 30 seconds across a 1
0C increment range.
The optimal melting temperature was always taken as
the higher temperature, under partially denaturing
conditions that did not exhibit profile degradation.
D DN NA A  S Se eq qu ue en nc ci in ng g
All heteroduplexes were subject to DNA sequencing
to determine the precise genetic change on a semi-
automated sequencing unit (model 310, Perkin-Elmer
Applied Biosystems Division, Foster City, CA) using
dideoxy sequencing of the PCR products was performed
using version 1 BIGDYE dideoxy sequencing Ready Rxn
kit (Perkin-Elmer, Foster City, CA).
R Re es su ul lt ts s
D DG GG GE E  A An na al ly ys si is s
From a total number of 130 patients 41 genetic
differences were identified by DGGE. 15 alterations
were found in hMSH2 and 26 in hMLH1. All alterations
in hMSH2 and hMLH1 were checked against the
published sequence (accession number U03911 and
U07418, respectively). A brief description of the affected
exon in either hMSH2 or hMLH1 is shown in Table 3. 
D DH HP PL LC C  A An na al ly ys si is s
All 130 samples that had been subjected to DGGE
analysis were tested by DHPLC to determine if this
methodology was at least as reliable as DGGE. All DNA
fragments analyzed were shorter than 420 base pairs in
length. A size limitation of 450 bp was chosen so that
the flow rate through the denaturing column and
denaturing  gradient  remained  constant.  The  only
parameter that was varied in this analysis was the column
temperature. Predicted DNA melting temperatures are
shown Table 3. The actual melting temperature of the
heteroduplexes varied from the predicted by a maximum
of 4
0C and most heteroduplexes melted at one of the
predicted temperatures. A total of 50 changes were
observed using DHPLC which included 9 additionalH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2003; 1(1) 42
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changes that were not detected by DGGE. DHPLC
analysis revealed that single base pair changes, deletions
or insertions could be readily identified as well as larger
base pair changes (for examples see Fig. 1). 
A potential difficulty with DHPLC analysis could be
the identification of more complex changes such as
common  polymorphisms  that  may  occur  in  the
proximity of a mutation. The identification of the
mutation  may  be  compromised  by  virtue  of  the
polymorphism. The heteroduplex melting profile of
exon  8,  hMLH1,  which  harbors  a  common
polymorphism (G to A) at position 655 and a mutation
(T deletion) at nucleotide 672 is shown in Fig. 2. Each
change  gave  a  distinct  and  unique  profile  both
individually and in combination.
There were nine additional changes not found by
DGGE that were apparent by DHPLC as indicated in
Table 3. The changes included a C to T substitution
at position +51 upstream of the splice site in exon 6
of hMLH1; a T to C substitution at position +6 in exon
13 of hMSH2; and a G to A substitution at position
884 in exon 10 of hMLH1. All three changes were
easily detected by DHPLC (see Fig. 3). Of particular
note was the identification of four substitutions and
one deletion that were detected in exon 7 of hMSH2,
which could not be observed when analysed by
DGGE. Interrogation of the sequence of exon 7 did
not reveal any unusual melting domains, which could
adversely  affect  the  melting  temperature  in  the
presence of a GC-clamp.
The analysis of fragments with DNA sequence
variations usually result in distinct melting profiles,
sometimes however, we observed similar profiles for
DNA fragments, harbouring non-identical changes
from the wild type allele and to each other, an example
is shown in Fig. 4. In this example two different genetic
changes, a substitution at position 965 (G to A) and
another at position 1009 (C to T) in exon 6 of hMSH2
resulted in very similar profiles whereas a 984 C to T
change was distinct. 
Finally, DNA melting temperatures and the resulting
melt profiles correlate very well when there are small
base composition changes (small insertions, deletions
and substitutions) but are not so well associated when
larger changes are present. It was our observation that
some changes were not as stable as others. 
D DG GG GE E  v ve er rs su us s  D DH HP PL LC C
Identification of unusual heteroduplexes by DHPLC
appeared to be more accurate than by DGGE (see
Table 4) as some of the conformers were undetectable
using this methodology. Evidence for this is shown in
Fig. 3. In total, we identified in our cohort of samples
9 examples where DGGE failed to detect heteroduplex
differences. Conversely, no DNA sequence variations
identified by DGGE were undetected by DHPLC.
In total, 50 changes were identified, 50 by DHPLC
and 41 by DGGE suggesting that DHPLC is a more
accurate method by which mutations can be identified,
in HNPCC patients using the described protocol. Within
the total sample population, 130 index patients were
studied by both DHPLC and DGGE. Using this approach
it was impossible to determine if other changes had been
missed by either of the two techniques, as direct
sequencing was not performed on any of the gene
fragments unless a change had been observed.
D Di is sc cu us ss si io on n
The analysis of genes associated with the colorectal
cancer predisposition HNPCC remains problematic
since there are a number of different genes, which
predispose to this disorder. In this report we have
focused on the two genes (hMSH2 and hMLH1) that
account for the majority of families that are consistent
with a diagnosis of HNPCC. Several different techniques
have been utilized in the identification of genetic
differences in hMSH2 and hMLH1, however, in this
T Ta ab bl le e   1 1. .   Increasing urea gradients used for DGGE analysis of all 
exons comprising hMLH1 and hMSH2
D De en na at tu ur ra an nt t   G Gr ra ad di ie en nt t G Ge en ne e/ /E Ex xo on n
15-30% HMSH2 exon 16
20-50% HMSH2 exon 4
25-45% HMSH2 exons 2, 8, 12
30-40% HMSH2 exons 3, 5, 7, 11
30-45% HMSH2 exons 6, 9
30-50% HMSH2 exons 14, 15
35-45% HMSH2 exon 1, hMLH1 exons
3, 9, 15
38-48% hMLH1 exon 7
40-50% hMLH1 exons 4, 5, 6, 8, 10, 16, 17
40-60% hMLH1 exon 18
40-70% hMLH1 exon 11
42-52% hMLH1 exon 19
45-55% hMSH2 exon 13, hMLH1 exons
2, 12, 13, 14
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T Ta ab bl le e   2 2. .   Primers used for DHPLC analysis of hMLH1 and hMSH2
h hM ML LH H1 1 F Fo or rw wa ar rd d R Re ev ve er rs se e
Exon 1 GAA CAT CTA GAC GTT TCC GTT AAG TCG TAG CCC TTA 
Exon 2  CAT TAG AGT AGT TGC AGA CTG CGC ACA AAC ATC CTG CTA CT
Exon 3  GAG TAA CAT GAT TAT TTA CTC  AAC AGG AGG ATA TTT TAC ACA
Exon 4 CAG TTC AGA TAA GGT TTC C TAT GAG TAA AAG AAG TCA GCA 
Exon 5  CTC TCT ACT GGA TAT TAA TTT G AAG CTT CAA CAA TTT ACT CTC C
Exon 6 CTA TCT TAA GAC CTC GCT  TAT GAG CAC TAG AAC ACA TT
Exon 7 TCT AGT GTG TGT TTT TGG CA CAT GGC TGA GAC TGA AAC 
Exon 8 AAT AAA TCC TTG TGT CTT CTG TTT TTA TAT AGG TTA TCG ACA TA
Exon 9 TTA TGC TTC AGA ATC TCT TTT C TGT TTC CTG TGA GTG GAT 
Exon 10 TTT GTG TGA ATG TAC ACC TG  TCT GTT CCT TGT GAG TCT
Exon 11 CTA AGG TAA TTG TTC TCT CTT A CAG AGA AGT AGC TGG ATG 
Exon 12 TAA TAC AGA CTT TGC TAC CAG GA GGT AGG CTG TAC TTT TCC CA 
Exon 13 CTG CAC TTC CTT TTC TTC AT CCT ATG CAT CCC AGG CA
Exon 14 AGG ATT CTA TTA CTT ACC TG TCT GCT TGT TCA CAC ACT CA
Exon 15 CAA CTG GTT GTA TCT CAA G TAC AAA TAA GAT ATT AGT GGA GA 
Exon 16 CTT GGG AAT TCA GGC TTC  AGA AGT ATA AGA ATG GCT GTC A
Exon 17 CAG CAT TAT TTC TTG TTC CC CAC ATG CAT GTA CCG AAA
Exon 18 ATT CGT ACC TAT TTT GAG GT TTG TAT AGG CCT GTC CTA 
Exon 19 AGC CAG GAC ACC AGT GTA GAA CAC ATC CCA CAG TGC
h hM MS SH H2 2 F Fo or rw wa ar rd d R Re ev ve er rs se e
Exon 1 CTT CAA CCA GGA GGT GAG AAA GGA GCC GCG CCA 
Exon 2 CAG CTA ATA CAG TGC TTG  GTA AAT TAA AAA GGA AGA TAA TTA C
Exon 3 GCT TAT AAA ATT TTA AAG TAT GTT C GCC TTT CCT AGG CCT GGA ATC TCC
Exon 4  TTC ATT TTT GCT TTT CTT ATT CC ATA TGA CAG AAA TAT CCT TC
Exon 5 CAG TGG TAT AGA AAT CTT CG CCA ATC AAC ATT TTT AAC CC
Exon 6  GTT TTC ACT AAT GAG CTT GCC ATG TGG GTA ACT GCA GGT TAC 
Exon 7  GAC TTA CGT GCT TAG TTG GTA TAT ATT GTA TGA GTT GAA GG
Exon 8 TTG TAT TCT GTA AAA TGA GAT C GCT TTT TAA AAA TAA CTA CTG C
Exon 9 GGA TTT TGT CAC TTT GTT CTG ATT ATT CCA ACC TCC AAT GAC 
Exon 10 GGT AGT AGG TAT TTA TGG AA CAT TTA GGG AAT TAA TAA AGG G
Exon 11 CAC ATT GCT TCT AGT ACA C CCA GGT GAC ATT CAG AAC
Exon 12 ATT CAG TAT TCC TGT GTA CA  CCA CAA AGC CCA AAA ACC A
Exon 13 CAA TCC ATT TAT TAG TAG CAG  TTC TAT CTT CAA GGG ACT AG
Exon 14 TAC CAC ATT TTA TGT GAT GGG TAC CAA GTT CTG AAT TTA GAG
Exon 15 TTC TCA TGC TGT CCC CTC A AGA GAA GCT AAG TTA AAC TAT G
Exon 16 TAA TTA CTC ATG GGA CAT TCA C TAC CTT CAT TCC ATT ACT GG
These primers were based on Liu et al. [9], Wijnen et al. [24], Kolodner et al. [27], Liu et al. [28], with minor modification.H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2003; 1(1) 44
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report we concentrated on comparing DGGE with
DHPLC analysis as there are several reports suggesting
that it is a superior mutation detection technique after
direct sequencing, see Ziao and Oefner [25]. The only
significant study to evaluate a number of different
mutation detection strategies and DHPLC focused on
single strand conformation polymorphism analysis
(SSCP), conformation sensitive gel electrophoresis
(CSGE) and two dimensional gene scanning (TDGS).
The results of this study indicate that DHPLC is as
sensitive as direct sequencing [19]. In the current study
an evaluation between DHPLC and DGGE has been
performed which further confirms the superior nature
of DHPLC against many other mutation detection
methods except perhaps direct sequencing. 
In this study we have investigated a series of families
that were diagnosed by virtue of the fact that they
adhered to the Amsterdam criteria [21]. There are other
criteria  that  could  have  been  used  but  for  this
comparative  analysis  it  was  considered  more
meaningful to test a minimum set of similar families,
which could be easily compared. 
Using the conditions described by Wijnen et al. [23,
24] we have found that DGGE analysis for mutation
detection is relatively rapid and accurate. A series of
changes were identified by this technique, which included
single base pair substitutions, deletions and insertions,
as well as larger genetic alterations [20]. DHPLC on the
other hand appears to be a more accurate method of
analysis since 9 additional mutations were identified using
this technique, which could not be detected by DGGE
analysis. Since we did not compare direct sequencing
with DHPLC analysis it is impossible to determine the
relative sensitivity of DHPLC, however, a recent report
suggests that the detection rate is very similar [19]. Of
particular interest was the finding of 5 different and distinct
mutations in exon 7 of hMSH2, which were not identified
by DGGE analysis. Examination of the predicted melting
temperatures does not suggest significantly different
melting temperatures in most domains except in the
region immediately adjacent to the GC-clamp, which
may interfere with the structure of the heteroduplex. This
may influence the role of the GC-clamp for DGGE
analysis, which is not present for DHPLC analysis.  
In  comparing  the  two  techniques  there  are
advantages and disadvantages of both methods. The
primary disadvantage of DGGE is the initial time
required to establish the appropriate melting conditions
to achieve optimal separation of mutant alleles. This
requires the use of 2-D gradient gels and knowledge
about the predicted DNA melting temperature. Several
programs have been developed to predict DNA melting
temperatures and most use the MELT 87 program
developed by in 1987 [26]. DHPLC as opposed to
DGGE does not require extensive 2-D gradient gel
electrophoresis but knowledge about the predicted DNA
melting temperature is required. The predicted melting
temperature proved very useful in determining the correct
temperatures for small changes such as single base pair
substitutions,  insertions  or  deletions.  When  larger
changes were analyzed at higher temperatures there was
a slight loss of predictive accuracy, which was most likely
due to the instability of the particular heteroduplex and
its  consequent  breakdown.  In  contrast  to  single
nucleotide polymorphism (SNP) analysis by DHPLC,
mutation screening by DHPLC should include analysis
at  lower  than  predicted  or  even  non-denaturing
temperatures to detect larger sequence changes. This
would increase the sensitivity of mutation detection by
DHPLC. All temperatures that were predicted were within
four degrees of the actual temperature. In summary, the
predictive power of the algorithm proved to be essential
for  rapid  analysis  and  compared  with  DGGE
optimization of the conditions for DHPLC also proved
to be particularly advantageous. The speed at which
DHPLC analysis is performed allowed the accurate
identification of melting temperature within 30 minutes
of analysis. The analysis of DNA fragments at different
temperatures for mutation detection must be exhaustively
analyzed compared to other applications for DHPLC.
An important difference between mutation detection and
for instance SNP analysis (where rapid throughput is
required) is the extent to which melting temperatures are
interrogated. Using DHPLC for SNP identification may
have limitations as some SNPs will not necessarily be
identified unless a range of temperatures are tested on
each segment of DNA under investigation.
Elution profiles appear to be consistent between
fragments of DNA that harbor the same change when
analyzed during one run of the system. Unique elution
profiles were found to generally occur for different
mutations offering the possibility of unique “family
mutation” profile analysis by DHPLC. We cannot
recommend this since some mutations due to different
base pair changes did result in elution profiles that were
almost identical. Taken together, we considered that
DHPLC is not an appropriate substitute for DNA
sequencing.
In comparison to DGGE, DHPLC represents a
relatively cost effective alternative. If capital costs are
ignored for DGGE and DHPLC, the running cost of
DHPLC is approximately 90 US cents per sample with
a throughput rate of approximately 5 minutes per
sample. DGGE is less expensive to perform with respect
to  consumable  costs  but  requires  post-resolution
manipulation to visualize the results, which effectivelyH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2003; 1(1) 45
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T Ta ab bl le e   3 3. . Mutations identified by DHPLC with the predicted and actual temperatures of detection and a summary of which mutations were
identified by DGGE
M Mu ut ta at ti io on n   D De es sc cr ri ip pt ti io on n F Fr ra ag gm me en nt t   S Si iz ze e P Pr re ed di ic ct te ed d    A Ac ct tu ua al l D De et te ec ct te ed d   b by y      
G Ge en ne e/ /E Ex xo on n ( (b bp p) ) T Te em mp pe er ra at tu ur re e T Te em mp pe er ra at tu ur re e D DG GG GE E/ /D DH HP PL LC C
D De et te ec ct te ed d
h hM ML LH H1 1
1 G to A (116) splice site 200 62 60 y/y
1 A to G (1) 200 62 60 y/y
1 A to G (112) 200 62 60 y/y
4 C to T (350)  191 54,59 59 y/y
4 G to A (+1) 191 54,59 54 y/y
6 C to T (+51) 230 56 56 y/y
7 T to G (554) 205 55 58 y/y
8 A to G (655) 149 48,53,55,58  58 y/y
9 A to G (790) splice site 181 56 58 y/y
10 G to A (884) 213 58 58 n/y
13 G to A (+13) 209 59 57,58,59 y/y
13 G to T (1535) 209 59 58,59 y/y
15 G to A (1731) splice site 210 49,54 54 y/y
16 AA to GC (1852-3) 259 55,60 55,60 y/y
17 G to T (1959) 178 59 58,59 y/y
17 G to A (1989) splice site 178 59 57,58,59 y/y
19 A to G (2253) 266 59 56,57 y/y
19 G to A (2147) 266 59 58,59 y/y
h hM MS SH H2 2
1 C of G (+8) 300 60 64/67 y/y
2 G to A (304) 244 53,54 54 n/y
3 C to T (547) 359 48/53/58 58 n/y
3 A to T (488) 359 48/53/58 58 y/y
6 C to T (1009) 240 57 57 y/y
6 G to A (965) 240 57 57 y/y
7 A to T (+2) 326 51/56 51 n/y
7 C to T (+7) 326 51/56 51 n/y
7 C to T (1216) 326 51/56 57 n/y
7 A to T (-2) 326 51/56 51 n/y
9  G to C (-1) 183 55 55 y/y
10 A to G (+12) 249 50,55 50,52,53,55 y/y
10 C to A (1632) 249 50,55 50,52,53 y/y
11 T to C (1669) 198 2 52,53 y/y
11 A to g (1690) 198 55 55 y/y
12 G to C (1968) 319 52,57 56,57 y/y
13 A to G (2157) 284 54,59 54,56 y/y
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T Ta ab bl le e   3 3. . continuation
D De el le et ti io on ns s
h hM ML LH H1 1
1 1 bp (9) 200 62 62 y/y
3 4 bp (+2, 208-9) 181 55 55 y/y
7 1 bp (588) 205 55 55 y/y
8 1 bp (672) 149 48,53,58  55 y/y
13 5 bp (1460-1464) 209 59 50,54,58,59 y/y
16 3 bp (1846-48) 259 55,60 53 y/y
17 2 bp (1986-1987) 178 59 57,58,59 y/y
19 1 bp (2114) 266 59 56 y/y
h hM MS SH H2 2
1 1 bp (163) 300 60 64,66,67 n/y
7 1 bp (1260) 326 51/56 57 n/y
9 1 bp (1408) 183 55 50,53,55 y/y
15 7 bp (2502-2508) 266 58 50,52,56 y/y
I In ns se er rt ti io on ns s
h hM ML LH H1 1
12 4 bp (1164) 410 55,60 50,55,60 y/y
I In nv ve er rs si io on ns s
h hM MS SH H2 2
8 23 bp (1338-1361) 212 53 53,50   y/y
F Fi ig g. .   1 1. . DHPLC and DGGE detection of base substitutions, deletions,
and insertions in genes associated with HNPCC. PCR products (5 µl)
were separated on a Helix DHPLC column under partially denaturing
conditions (at the indicated temperatures) using a flow rate of 0.45
ml/min and an increasing linear acetonitrile gradient. Arrows on DHPLC
traces indicate the presence of a heteroduplex species and asterisks
on DGGE gels indicate the sample represented by DHPLC analysis.
(A) 116G to A introducing a stop codon in exon 1 of hMLH1. (B) 1460
(del5) in exon 13 of hMLH1 (C) 1164 (ins4) in exon of 12 hMLH1
F Fi ig g. .   2 2. .   Mutations and polymorphisms in the same PCR fragment
distinguished by their DHPLC elution profile. PCR products (5 µl)
were separated on a Helix DHPLC column under partially
denaturing conditions at the indicated temperature using a flow
rate of 0.45ml/min and an increasing linear acetonitrile gradient.
Arrows on DHPLC traces indicate the presence of heteroduplex
species. The polymorphism is a 655G to A substitution and the
mutation a 672delT, both in exon 8 of the hMLH1 gene. (A)
sample homozygous for the polymorphism and heterozygous for
the mutation. (B) sample heterozygous for both the polymorphism
and  the  mutation;  (C)  sample  homozygous  for  both  the
polymorphism and mutation; (D) sample heterozygous for the
polymorphism and homozygous for the mutation; (E) same as D
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make this analytical procedure more expensive than
DHPLC. Of particular note is the speed of genetic
screening by DHPLC, which is far superior to DGGE
and  indeed,  DNA  sequencing,  when  used  as  a
screening tool. The most expensive consumable cost is
replacement of the column, which should be used
according to the manufacturers’ instructions to maximize
column life. So long as this number of injections can
be  assured  from  the  column  the  cost  effective
advantage of DHPLC is much greater than DGGE.
The use of DHPLC analysis for the identification of
mutations represents a significant move forward in the
diagnosis of HNPCC. There are, however, aspects of
DHPLC analysis that require attention prior to this
approach being accepted as a standard laboratory
procedure. A potential limitation of this technique is
the variability in column life, which may be a function
of  temperature  particularly  if  the  columns  are
continuously used at a temperature greater than 60
0C
(Varian Inc., Melbourne, personal communication).
The  DNA  denaturing  temperature  estimates
generated from the DHPLC-MELT algorithm predicted
DNA melting temperatures relatively accurately for
single base changes and single base pair insertions
and deletions. Larger deletions (over 3 base pairs) or
complex changes are also easily identified with careful
selection of column temperature.
In summary, DHPLC represents a cost-effective and
rapid approach to the identification of genetic changes
in HNPCC. DHPLC technology accelerates mutation
analysis with improvements in sensitivity and specificity
resulting in a more cost-effective approach to mutation
detection. 
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